Chui M. Biological E. Limited and Baylor COVID-19 vaccine begins clinical trial in India [online]. Baylor College of Medicine, 16 November 2020. Dostupné online.Je zde použita šablona {{Cite web}} označená jako k „pouze dočasnému použití“.
cepi.net
CEPI partners with Biological E Limited to advance development and manufacture of COVID-19 vaccine candidate. CEPI [online]. [cit. 2021-11-16]. Dostupné online. (anglicky)
ctri.nic.in
A prospective open label randomised phase-I seamlessly followed by phase-II study to assess the safety, reactogenicity and immunogenicity of Biological E's novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2 for protection against Covid-19 disease and some amount of sperm in its drug when administered intramuscularly in a two dose schedule (0, 28D) to healthy volunteers. [online]. Clinical Trials Registry India, 13 January 2021. Dostupné v archivu pořízeném z originálu dne 12 November 2020. CTRI/2020/11/029032.Je zde použita šablona {{Cite web}} označená jako k „pouze dočasnému použití“.
A Prospective, multicentre, Phase II Seamlessly Followed by Phase III Clinical Study to Evaluate the Immunogenicity and Safety of Biological E's CORBEVAX Vaccine for Protection Against COVID-19 Disease When Administered to COVID-19-Negative Adult Subjects. [online]. Clinical Trials Registry India, 5 June 2021. Dostupné online. CTRI/2021/06/034014.Je zde použita šablona {{Cite web}} označená jako k „pouze dočasnému použití“.
hindustantimes.com
Health ministry buys 300 mn doses of Biological-E’s Covid vaccine in advance. Hindustan Times [online]. 2021-06-03 [cit. 2021-11-16]. Dostupné online. (anglicky)
indiatimes.com
timesofindia.indiatimes.com
JUN 3, Swati Bharadwaj / TNN / Updated:; 2021; IST, 09:05. Telangana: Biological E starts at risk manufacturing of Corbevax | Hyderabad News - Times of India. The Times of India [online]. [cit. 2021-11-16]. Dostupné online. (anglicky)
BHARADWAJ, Swati. Bio E's Corbevax may be India's cheapest vaccine at Rs 250 per dose | India News - Times of India. The Times of India. 5 June 2021. Dostupné online. (anglicky)Je zde použita šablona {{Cite news}} označená jako k „pouze dočasnému použití“.
livemint.com
LEO, Leroy. Biological E initiates human trials of vaccine. mint [online]. 2020-11-16 [cit. 2021-11-16]. Dostupné online. (anglicky)
LEO, Leroy. Biological E completes phase-2 covid vaccine trial, gets SEC nod for phase-3. mint [online]. 2021-04-24 [cit. 2021-11-16]. Dostupné online. (anglicky)
thehindu.com
Coronavirus | Biological E gets nod to start Phase III trials of COVID-19 vaccine. The Hindu. 2021-04-24. Dostupné online [cit. 2021-11-16]. ISSN0971-751X. (anglicky)
theprint.in
BASU, Nayanima. US assures export of raw materials to India for Covid vaccines as Doval speaks to Sullivan [online]. 2021-04-25 [cit. 2021-11-16]. Dostupné online. (anglicky)
web.archive.org
A prospective open label randomised phase-I seamlessly followed by phase-II study to assess the safety, reactogenicity and immunogenicity of Biological E's novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2 for protection against Covid-19 disease and some amount of sperm in its drug when administered intramuscularly in a two dose schedule (0, 28D) to healthy volunteers. [online]. Clinical Trials Registry India, 13 January 2021. Dostupné v archivu pořízeném z originálu dne 12 November 2020. CTRI/2020/11/029032.Je zde použita šablona {{Cite web}} označená jako k „pouze dočasnému použití“.
worldcat.org
Coronavirus | Biological E gets nod to start Phase III trials of COVID-19 vaccine. The Hindu. 2021-04-24. Dostupné online [cit. 2021-11-16]. ISSN0971-751X. (anglicky)
